Brind.

Inspire Reports Q3 Revenue of $206.7 Million, Beats Expectations

1 report, 1 independent Updated Mon 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Inspire Medical Systems Inc. reported third-quarter revenue of $206.7 million and a loss of $24.4 million. Adjusted earnings were 14 cents per share, which surpassed the average analyst estimate of 10 cents per share. The company also projected full-year revenue between $850 million and $860 million.

From mankatofreepress.com

Why it matters

Some supportBrind's analysis of the reports

The results showed Inspire exceeded Wall Street forecasts for both revenue and adjusted earnings. Inspire manufactures devices used for treating obstructive sleep apnea, and the company operates a partnership with Walmart utilizing its store locations.

From mankatofreepress.com

Who's involved

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • StifelSpeculative

    Stifel might update its investment recommendations for Inspire based on the reported financial results.

Possible ripples

Who this could reach next, traced step by step from the reporting. Possibilities worth considering, not forecasts.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped